The Canadian Cancer Clinical Trials Network (3CTN)

The Canadian Cancer Clinical Trials Network (3CTN) is a pan-Canadian initiative to improve the efficiency and quality of clinical trials in Canada.

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

Our 3CTN Impact Report for 2022-23 is now available!

This report highlights achievements and performance metrics in our first year of the Network’s Strategic Plan for 2022 - 2027. Read here: https://t.co/I3cm7ryahY

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

Happy International Clinical Trials Day!

Clinical trials are at the heart of better treatments, better care & better health outcomes.

We thank our incredible Network sites, committee members, patient partners, funders, and partner organizations who make this work possible.

[PiPER@UHN @PiPER_UHN]

Today Dr. Craven is presenting impactful work from the PiPER team at the 3CTN Annual Stakeholder Meeting 2024. She is featuring the Patient Engagement in Research Toolkit and the Bare Bones Podcast!

#3CTNASM2024

[Carley McPherson @cmcpher]

Big thanks to the organizers of #3CTNASM2024 for including @LakeridgeHealth in this important session! A special shoutout to Kelly Fusco for representing us and contributing to the conversation on our centralized services and successful reduction of trial activation times.

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

Yesterday, we wrapped up Day 2 of #3CTNASM2024! Profound thanks to session facilitators, presenters, collaborative partners and our members who’s shared knowledge and expertise will benefit improved access to, and efficient conduct of #cancerclinicaltrials across Canada.

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

The #3CTNASM2024 final session centered on initiatives underway to help optimize trial teams' functional capacity, Patient Engagement and access available learning opportunities @CANTAPTALENT @PiPER_UHN. Thanks to Christine Samara @Sunnybrook for facilitating!

[Don Wood @thisisdonwood]

@3ctnNews Great meeting so far - always great to share the stage presenting our work on the CCS Clinical Trial Forum we held yesterday with Judy Needham! #3CTNSM2024

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

Facilitator Stéphanie Cyr @chudequebec and #3CTNASM2024 Session 3 presenters held everyone's attention with applied learnings arising from recent audits and inspections, applied conduct of #CRAFTDCT, and optimized use of #RealTime CTMS by BC Cancer Centres.

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

Attendees at #3CTNASM2024 showing off their skills at the Cup Toss and Trivia Challenge! Thank you to our partners at @EDGEclinical CTMS for donating some amazing prizes!

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

Day 2, Session 2, of #3CTNASM2024 delved into topical and exciting advances in reducing trial activation times by our Cancer Centres & partners at #OCREB and #HREBA. Thank you to Brenda Kowaleski @HamHealthSci for facilitating!

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

Day 2 of the 3CTN Annual Meeting kicked off with presentations that focused on innovative solutions for improving access to academic cancer clinical trials. Thank you to Carla Bossart-Pletzer from @OICR_news and Kathy Brodeur-Robb from @C17Council for facilitating! #3CTNASM2024

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

Kicking off Day 2 of our #3CTNASM2024! The agenda is packed with great presentations and speakers aimed at advancing the academic cancer clinical trial landscape!

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

That's a wrap for Day 1 of #3CTNASM2024! Our workshop surpassed expectations for knowledge mobilization and attendees brainstormed practical next steps for implementing local and pan-Canadian EDI initiatives for transforming trial access.

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

An inspiring presentation and valuable insights from Vinesha Ramasamy @ayacan_cancer about the opportunities for improving equity in clinical practices for Canada's diverse population! #3CTNASM2024

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

We're kicking off Day 1 of our #3CTNASM2024 meeting with this year's 3CTN EDI Workshop! The workshop brings together 120+ in-person and virtual Network members and our partners from across Canada to improve EDI best practices within the conduct of cancer clinical trials.

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

Over the last few weeks, our team had the pleasure of hosting member cancer centres for in-person @EDGEclinical training. It was a great opportunity to learn, collaborate, and connect with each other!

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

We have enriched the Equity, Diversity and Inclusion (EDI) Framework and Toolkit with additional resources and best practices aimed at addressing the unique needs of sexual and gender diverse (SGD) communities with @QueeringCancer ! View here: https://t.co/Dq46xkanz2

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

We are excited to share the latest edition of our EDI Framework and Toolkit, developed in collaboration with Kim Meeking, Co-Lead @QueeringCancer. View here: https://t.co/Dq46xkanz2

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

3CTN will be hosting the next impACCT Virtual Rounds session on October 22, 2024, at 12 pm ET.

We will be discussing the following two trials:
1. (CCTG) SC.29
2. (CCTG) AL.6 / MM1YA-CTG01
@CDNCancerTrials

To learn more and to register, click here :https://t.co/HBsoKt2nFV

[The Canadian Cancer Clinical Trials Network (3CTN) @3ctnNews]

Our September Portfolio Watch is now available! Check it out: https://t.co/SoaoZWO51V

[Dr. Perri Tutelman @DrPerriTutelman]

The SECOND national survey for the AYA Cancer Priority Setting Partnership is now live! 📣

In this survey, we are asking AYAs, their loved ones, and clinicians in 🇨🇦 to pick which priorities are most important for future research

➡️https://t.co/ijYgzLe42u

#AYACancerPSP